Acute Ischemic Stroke in Patients With Active Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorOsaka University
About this trial
The goal of this multicenter prospective observational study, conducted at 24 hospitals in Japan, is to learn about recurrent ischemic stroke in people with active cancer who develop acute ischemic stroke. One of the main objectives is to evaluate how often ischemic stroke recurs during follow-up.
The main questions this study aims to answer are:
* How often does ischemic stroke recur within 3 months after the initial stroke? * Which clinical factors may be associated with recurrent ischemic stroke? * What other clinical outcomes occur during follow-up?
Participants will receive medical care determined by their treating physicians. Researchers will collect information about participants' cancer, stroke characteristics, test results, treatments, recurrent ischemic stroke, and other clinical outcomes. Researchers will also explore whether clinical factors are associated with recurrent ischemic stroke and other outcomes. This study will not assign participants to a specific treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Acute ischemic stroke diagnosed within 7 days after symptom onset or the time last known well.
Active cancer at the time of the index stroke, as defined below.
Disqualifiers
The patient or a legally acceptable representative indicates that the patient does not wish to participate.
The investigator considers enrolment inappropriate.
Trial population
The study population will consist of participants with acute ischemic stroke and active cancer who receive medical care at participating hospitals in Japan. Eligible participants will be enrolled prospectively during the study enrollment period.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
500 Participants
are grouped into 1 trial groupGroup A: Participants with acute ischemic stroke and active cancer
Trial outcomes
Primary outcomes
1
Percentage of Participants With Recurrent Ischemic Stroke Within 3 Months
The percentage of participants who experience recurrent ischemic stroke during follow-up. Recurrent ischemic stroke will be determined according to the criteria prespecified in the study protocol.
Time frame
From enrollment through 3 months of follow-upSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov